Clinical trial
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
NCT01191268
Study timeline
Study start (unknown)2010-11-01Date precision: month
Registry last updated2014-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
Insulin GlargineDRUG · verified · RxNorm: insulin glargine
LY2189265DRUG
Insulin LisproDRUG · verified · RxNorm: insulin lispro
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01191268 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.